Patents by Inventor Mika Kauppala

Mika Kauppala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220047540
    Abstract: Compounds of formula (I), wherein R1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.
    Type: Application
    Filed: September 1, 2021
    Publication date: February 17, 2022
    Inventors: Marko AHLMARK, David DIN BELLE, Mika KAUPPALA, Anne LUIRO, Taina PAJUNEN, Jarmo PYSTYNEN, Eija TIAINEN, Matti VAISMAA, Josef MESSINGER
  • Publication number: 20200352898
    Abstract: Compounds of formula (I), wherein R1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.
    Type: Application
    Filed: June 5, 2020
    Publication date: November 12, 2020
    Inventors: Marko AHLMARK, David DIN BELLE, Mika KAUPPALA, Anne LUIRO, Taina PAJUNEN, Jarmo PYSTYNEN, Eija TIAINEN, Matti VAISMAA, Josef MESSINGER
  • Publication number: 20200009103
    Abstract: Compounds of formula (I), wherein R1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.
    Type: Application
    Filed: May 17, 2019
    Publication date: January 9, 2020
    Inventors: Marko AHLMARK, David DIN BELLE, Mika KAUPPALA, Anne LUIRO, Taina PAJUNEN, Jamo PYSTYNEN, Eija TIAINEN, Matti VAISMAA, Josef MESSINGER
  • Publication number: 20190029990
    Abstract: Compounds of formula (I), wherein R1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.
    Type: Application
    Filed: July 30, 2018
    Publication date: January 31, 2019
    Inventors: Marko Ahlmark, David Din Belle, Mika Kauppala, Anne Luiro, Taina Pajunen, Jarmo Pystynen, Eija Tiainen, Matti Vaismaa, Josef Messinger
  • Publication number: 20170165219
    Abstract: Compounds of formula (I), wherein R1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.
    Type: Application
    Filed: August 2, 2016
    Publication date: June 15, 2017
    Inventors: Marko AHLMARK, David DIN BELLE, Mika KAUPPALA, Anne LUIRO, Taina PAJUNEN, Jarmo PYSTYNEN, Eija TIAINEN, Matti VAISMAA, Josef MESSINGER
  • Patent number: 9458128
    Abstract: Compounds of formula (I), wherein R1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.
    Type: Grant
    Filed: May 23, 2013
    Date of Patent: October 4, 2016
    Assignee: ORION CORPORATION
    Inventors: Marko Ahlmark, David Din Belle, Mika Kauppala, Anne Luiro, Taina Pajunen, Jarmo Pystynen, Eija Tiainen, Matti Vaismaa, Josef Messinger
  • Publication number: 20150218124
    Abstract: Compounds of formula (I), wherein R1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.
    Type: Application
    Filed: May 23, 2013
    Publication date: August 6, 2015
    Inventors: Marko Ahlmark, David Din Belle, Mika Kauppala, Anne Luiro, Taina Pajunen, Jarmo Pystynen, Eija Tianen, Matti Vaismaa, Josef Messinger